ArticleAdvanced biomedical research2025
The Expression Pattern of Immune Checkpoint Genes Related to Immune Regulatory Cells (GITR and LAG-3) in Colorectal Cancer Patients.
Article in Advanced biomedical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Targeting KITENIN signaling in cancer progression and therapeutic resistance: mechanistic insights and future directions.Cancer cell international · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Immune cells that predominantly contribute to the homeostasis and regulation of the immune system are regulatory T (T reg) cells. The specific markers of these cells, which are considered as immune control points, play a role in the function and regulation of the immune activity of these cells, and their expression can be related to clinicopathological features of colorectal cancer (CRC). The aim of the present study was to evaluate the expression changes of immune checkpoint genes of T reg cells (glucocorticoid-induced tumor necrosis factor receptor [GITR] and lymphocyte-activation gene 3 [LAG-3]) in patients with CRC. Materials and Methods: 30 peripheral blood mononuclear cell (PBMC) samples from patients with CRC and 30 samples from healthy individuals were studied. A quantitative polymerase chain reaction (qPCR) was completed for analyzing the relative expression of immune checkpoint genes of T reg cells (GITR and LAG-3). The relationship with clinicopathological features and diagnostic values of the genes was examined. REST and SPSS software were used for statistical analyses. Results: The results showed that the expression of LAG-3 (but not GITR) gene in the population of PBMCs of patients with CRC has a significant decrease in expression compared to healthy individuals. Further analyses showed that these expression changes were not related to the clinicopathological characteristics of the CRC patients. Conclusion: The expression pattern of immune checkpoint genes of T reg cells in CRC patients may have a clinical value. Hence, investigation of a larger population of patients can be useful in order to evaluate their diagnostic power in differentiating between healthy and tumor patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.